Dr. Freddy Yan received his Ph.D. in Neuroscience from Helsinki University, Finland. During his tenure as a researcher in Dr. Henri Huttunen’s group, Dr.Yan developed a drug discovery platform for the high throughput screening of compounds targeting neurodegenerative diseases. In 2019-2021, Dr. Yan worked as a senior medical scientific liaison and medical affairs associate manager at GlaxoSmithKline, China. He is currently employed at Neurotar as an application specialist. In this role, Dr. Yan is supporting labs and distribution partners all over the world in their quest for an optimal solution for correlating neuronal signaling with behavior in awake mice.

Dr.闫旭神经学博士毕业于芬兰赫尔辛基大学。在Dr.Henri Huttunen团队做大学研究员期间，Dr.闫旭致力于开发高通量筛选针对神经退行性疾病靶点药物的平台。2019-2021年，Dr.闫旭在中国葛兰素史克担任过资深医学联络官以及医学事务副经理。他目前在芬兰Neurotar公司就职，担任应用专家，并致力于支持世界各地的实验室和代理合作伙伴，为将清醒小鼠神经信号与行为学研究联系起来提供最佳的解决方案。